Fiche centre
Ospedale Santa Maria della Misericordia
Perugia — Italy
Essais liés2clinical trials
VillePerugialocalisation
PaysItalylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06459024
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Tacabrutideg | Cancer | Phase 3 | NCT06846671 | CaDAnCe-302 — A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors | RECRUITING |
| IMPACT STREAM — Master Framework For Relapse or Refractory Acute Myeloid Leukemia | Cancer | À vérifier | NCT06459024 | IMPACT STREAM — Master Framework For Relapse or Refractory Acute Myeloid Leukemia | RECRUITING |